title: Severe hypoglycemia after initiation of anti-tumor necrosis factor therapy with etanercept in a patient with generalized pustular psoriasis and type 2 diabetes mellitus.
authors.forename: Carlos G
authors.initials: CG
authors.lastname: Wambier
authors.forename: Maria C
authors.initials: MC
authors.lastname: Foss-Freitas
authors.forename: Renato S
authors.initials: RS
authors.lastname: Paschoal
authors.forename: Marilia V
authors.initials: MV
authors.lastname: Tomazini
authors.forename: João C
authors.initials: JC
authors.lastname: Simão
authors.forename: Milton C
authors.initials: MC
authors.lastname: Foss
authors.forename: Norma T
authors.initials: NT
authors.lastname: Foss
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced*; D007074:Immunoglobulin G / Q000009:adverse effects*; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept